title: [Metabolic correction of bile outflow in patients with obstructive jaundice].
abstract: The purpose of research is to study the influence of infusion therapy structure on the of metabolic disorders and biliary excretion correction in patients with obstructive jaundice.
  
  
  METHODS
  The study was carried out in 139 patients divided into 3 groups with the same volume of infusion therapy (1600 ml/day). In 1-St group (54 patients) infusion therapy included ringer's lactate and 10% glucose solution in the ratio of 1:1. In the 2nd group (37 patients) infusion therapy was sterofundine - G-5. In the 3rd group (48 patients) in infusion therapy have included remaxol with dosage of 800 ml/day.
  
  
  RESULTS
  The inclusion of remaxol and sterofundin in infusion therapy leads to the improvement of biliary excretion in the early postoperative period versus ringer's lactate and 10% glucose solution. Remaxol has the advantage in metabolic disorders and biliary excretion correction versus sterofundine-G-5.
authors: V B
authors: VB
authors: Semenov
authors: A Iu
authors: AIu
authors: Iakovlev
authors: R M
authors: RM
authors: Zaĭtsev
authors: E M
authors: EM
authors: Smirnova
authors: D N
authors: DN
authors: Ulitin
authors: K V
authors: KV
authors: Mokrov
mesh_terms: D001646:Bile / Q000378:metabolism*; D002767:Cholecystostomy; D002768:Choledochostomy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007262:Infusions, Intravenous; D007552:Isotonic Solutions / Q000008:administration & dosage / Q000627:therapeutic use*; D041781:Jaundice, Obstructive / Q000378:metabolism* / Q000601:surgery / Q000628:therapy*; D015227:Lipid Peroxidation / Q000187:drug effects; D009930:Organic Chemicals / Q000008:administration & dosage / Q000627:therapeutic use; D011446:Prospective Studies; D000077331:Ringer's Solution; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007552:Isotonic Solutions; D009930:Organic Chemicals; C555877:Remaxol; D013386:Succinates; C052337:sterofundin; D000077331:Ringer's Solution